LC
MGNX icon

Lindbrook Capital’s MacroGenics MGNX Stock Holding History

Lindbrook Capital’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-273
Closed -$1.46K – 2772
2023
Q2 		$1.46K Sell
273
-105
-28% -$648 ﹤0.01% 2271
2023
Q1 		$2.71K Buy
+378
New +$2.28K ﹤0.01% 2112

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lindbrook Capital's MGNX Position: Q3 2023 in Review

Lindbrook Capital sold out of MacroGenics (MGNX) in Q3 2023, closing a stake of 273 shares — an estimated $1.46K sold.

Lindbrook Capital first reported a position in MGNX in Q1 2023 and held it in 2 quarters. The position peaked at $2.71K in Q1 2023. 127 funds tracked by Wall St. Rank hold MGNX as of Q3 2023.

  • Lindbrook Capital reported no remaining MacroGenics position as of Q3 2023 after selling out during the quarter.
  • Lindbrook Capital sold 273 MacroGenics shares in Q3 2023, an estimated $1.46K.
  • Lindbrook Capital first reported a position in MacroGenics in Q1 2023 and held it in 2 quarters.
  • Lindbrook Capital's MacroGenics position peaked at $2.71K in Q1 2023.
  • 127 funds tracked by Wall St. Rank held MacroGenics as of Q3 2023.

Based on Lindbrook Capital's 13F filing for Q3 2023, filed 25 Oct 2023.